Form 8-K, current report

MapLight Therapeutics, Inc., 8-K filed 2026-08-13

Published 13 Aug 2026 · retrieved 14 Aug 2026, 02:30 EDT · version 1Official source

The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.

Filing record

1

8-K filed with the Securities and Exchange Commission by MapLight Therapeutics, Inc. (CIK 0001770069) on 2026-08-13.

2

Accession number 0001193125-26-349490. EDGAR reports the filing package as 4 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1770069/000119312526349490/0001193125-26-349490-index.htm.

Items reported on the cover

1

Item 1.01: Entry into a Material Definitive Agreement

2

Item 2.02: Results of Operations and Financial Condition

3

Item 3.02: Unregistered Sales of Equity Securities

4

Item 7.01: Regulation FD Disclosure

5

Item 9.01: Financial Statements and Exhibits